@article{f554128a27784906acf081a2e3e573f8,
title = "Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neck.",
author = "Guilherme Rabinowits and Leela Bhupalam and Miller, \{Donald M.\} and Kloecker, \{Goetz H.\} and Laber, \{Damian A.\}",
note = "Fifteen patients with refractory SCCHN were enrolled. All patients had relapsed after surgery and had failed radiation therapy. Eighty-seven percent (13) had progressed after chemotherapy. The most common toxicities were grades 1 or 2 fatigue and anemia. There was a 13\% partial response rate and 33\% stable disease rate for a clinical benefit of 46\% by Response Evaluation Criteria in Solid Tumors criteria.",
year = "2010",
month = jan,
day = "2",
doi = "10.1097/MAJ.0b013e3181c4bd91",
language = "American English",
volume = "339",
journal = "The American Journal of the Medical Sciences",
}